NCT07129824

Brief Summary

Chronic gastritis (CG) is a prevalent and persistent inflammatory condition that affects the gastric mucosa, carrying a significant global burden. Although CG may remain asymptomatic in some cases, many patients experience gastrointestinal (GI) symptoms such as epigastric pain, bloating, nausea, vomiting, and appetite loss. Diet plays a crucial role in both the development and progression of CG. there is a significant relationship between dietary behaviors, GI symptoms, and quality of life (QoL) in CG patients. Poor dietary habits have been associated with increased symptom severity, while healthier eating behaviors correlate with better physical and mental well-being. Most research has focused on dietary risk factors in gastric cancer patients, with limited studies exploring their impact on CG and its symptoms. Furthermore, while nutritional adjustments are frequently recommended in clinical practices such as reducing coffee and alcohol intake and avoiding heavy smoking, there is a lack of comprehensive studies evaluating the relationship between eating habits, food preferences, and symptom severity in CG patients

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
246

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Aug 2025Aug 2026

Study Start

First participant enrolled

August 1, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

August 9, 2025

Last Update Submit

August 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • measure the percentage of patients with chronic gastritis who follow unhealthy dietary habits.

    measure the percentage of patients with chronic gastritis who follow unhealthy dietary habits by standardized questionnaire consisted of three main sections: 1. Sociodemographic Characteristics (age, sex, educational level, height, and weight). 2. Gastrointestinal Symptoms (stomachache, gastric distention, hiccup, belching, heartburn, acid reflux, abdominal bloating, nausea, abdominal pain, vomiting, diarrhea, early satiety, appetite changes, food intake quantity, and symptom-related triggers) 3. Dietary Factors (eating habits, food preferences)

    12 months

Study Arms (1)

Chronic gastritis patients

Adults aged 18 years or above with gastrointestinal symptoms for a week or longer exclude who reported having other digestive system diseases such as peptic ulcer, pancreatitis, hepatitis, and cirrhosis also serious heart, brain, liver, kidney and hematopoietic system dysfunction. Severe mental illness (such as schizophrenia, depression, and anxiety), and food or drug allergies, pregnancy, or breastfeeding and symptoms that occurred after taking prescription or over-the-counter drugs, especially aspirin or other pain relievers are also excluded

Other: Observation

Interventions

Observe the effect of eating habits and food preferences on symptoms of chronic gastritis

Chronic gastritis patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 years or above with gastrointestinal symptoms for a week or longer.

You may qualify if:

  • Adults aged 18 years or above
  • All consecutive patients with gastrointestinal symptoms for a week or longer.

You may not qualify if:

  • Subjects who reported having other digestive system diseases such as peptic ulcer, pancreatitis, hepatitis, and cirrhosis
  • Serious heart, brain, liver, kidney, or hematopoietic system dysfunction or other serious diseases
  • Severe mental illness (such as schizophrenia, depression, and anxiety)
  • Food or drug allergies, pregnancy, or breastfeeding
  • Symptoms that occurred after taking prescription or over-the-counter drugs, especially aspirin or other pain relievers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag university hospitals

Sohag, Sohag Governorate, Egypt

Location

Related Publications (1)

  • Azer SA, Awosika AO, Akhondi H. Gastritis. 2024 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK544250/

    PMID: 31334970BACKGROUND

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Ola A fathy, Family medicine resident

    Sohag University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ola A fathy, Family medicine resident

CONTACT

Tasneem M Ali, Ass.Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Family medicine resident at Sohag Health Directorate

Study Record Dates

First Submitted

August 9, 2025

First Posted

August 19, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Locations